Submission Process

Submissions are due on or before January 31, 2019 via the submission form.

We encourage pre-submitting by sending entries before December 15, 2018, to receive feedback and the opportunity to re-submit ahead of the final deadline.

Each submission will be reviewed as it is submitted until the deadline. Applicants are encouraged to submit their ideas as soon as they are ready.

Submissions must be brief and clear. They should be submitted as a PDF no longer than three pages, plus any appendices or citations an applicant deems relevant. Applicants are encouraged to review the Case Examples section before making a submission.

All submitted ideas will remain confidential and the property of the applicant and/or their institution.

Judging Criteria

All submissions will be evaluated on the following:

  • Inclusion of at least one prescription medication
  • A strong scientific basis for the hypothesis
  • Level of seriousness of potential interaction/serious adverse event
  • Proposed quantifiable clinical/non-clinical ways to test the hypothesis
  • Originality – the hypothesis must not have been previously studied or currently addressed on an existing drug label
  • Finalists will be notified by February 15, 2019